FCCC LOGO Faculty Publications
Motzer RJ , Jonasch E , Michaelson MD , Nandagopal L , Gore JL , George S , Alva A , Haas N , Harrison MR , Plimack ER , Sosman J , Agarwal N , Bhayani S , Choueiri TK , Costello BA , Derweesh IH , Gallagher TH , Hancock SL , Kyriakopoulos C , LaGrange C , Lam ET , Lau C , Lewis B , Manley B , McCreery B , McDonald A , Mortazavi A , Pierorazio PM , Ponsky L , Redman BG , Somer B , Wile G , Dwyer MA , Hammond LJ , Zuccarino-Catania G
Kidney Cancer, Version 2.2020 Featured Updates to the NCCN Guidelines
Journal of the National Comprehensive Cancer Network. 2019 Nov;17(11) :1279-1285
PMID: WOS:000499645400003   
Back to previous list
Abstract
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.
Notes
Motzer, Robert J. Jonasch, Eric Michaelson, M. Dror Nandagopal, Lakshminarayanan Gore, John L. George, Saby Alva, Ajjai Haas, Naomi Harrison, Michael R. Plimack, Elizabeth R. Sosman, Jeffrey Agarwal, Neeraj Bhayani, Sam Choueiri, Toni K. Costello, Brian A. Derweesh, Ithaar H. Gallagher, Thomas H. Hancock, Steven L. Kyriakopoulos, Christos LaGrange, Chad Lam, Elaine T. Lau, Clayton Lewis, Bryan Manley, Brandon McCreery, Brittany McDonald, Andrew Mortazavi, Amir Pierorazio, Phillip M. Ponsky, Lee Redman, Bruce G. Somer, Bradley Wile, Geoffrey Dwyer, Mary A. Hammond, Lydia J. Zuccarino-Catania, Griselda 1540-1413